Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.
This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.
This cohort study analyzes changes in cerebrospinal fluid (CSF) biomarkers and cognition among individuals in different stages of the Alzheimer disease clinical spectrum.
This qualitative study evaluates what factors clinicians and caregivers of people living with dementia in Great Britain perceive to shape treatment intensity toward the end…
This scoping review evaluates whether clinical practice guidelines in infectious disease include ethical considerations.
This JAMA Insights offers evidence-based communication strategies for addressing patient treatment expectations, which can improve outcomes and reduce adverse effects.
Dr. Tanner Bommersbach (University of Wisconsin School of Medicine and Public Health) and Dr. Greg Rhee (University of Connecticut and Yale University School of Medicine)…
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
Nightmares might not only signal hidden stress but also predict faster aging, early death, and even suicide risk.
The US Food and Drug Administration (FDA) recently approved lenacapavir, marketed as Yeztugo, as the first twice-yearly preexposure prophylaxis (PrEP) that reduces HIV risk.
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).